Scholars Central

Mini reviewPublished 2016

Short Review of Current Research on the Development of Hypoestoxide as a Therapeutic Agent for Parkinsons Disease

Authors: Emmanuel A Ojo-Amaize, Howard B Cottam

Journal of Neurology & Neurophysiology

Volume 7 · Issue 4 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Parkinson’s disease (PD) is a common neurodegenerative disorder belonging to a heterogeneous group of disorders with α-synuclein pathology and PD dementia. Hypoestoxide is being developed to combat microgliosis, astrogliosis, loss of dopaminergic neurons, motor behavioral deficits and α-synuclein pathology in PD.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neurology & Neurophysiology
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Emmanuel A Ojo-Amaize”
  • BylineArticles whose byline prints “Howard B Cottam”